OGOren N. Gottfried

Oren N. Gottfried

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oren N. Gottfried has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Carlos A. Bagley

    Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA

    4 shared publications
  • Joel R. Martin

    Department of Neurological Surgery, University of California, San Diego, La Jolla, CA 92037, USA

    4 shared publications
  • Isaac O. Karikari

    Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA

    3 shared publications
  • Maragatha Kuchibhatla

    Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC 27710, USA

    3 shared publications
  • Owoicho Adogwa

    Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina

    3 shared publications
  • Timothy Y. Wang

    Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA

    3 shared publications

Latest Publications

  • Race as a predictor of postoperative hospital readmission after spine surgery

    by Joel R. Martin, Timothy Y. Wang, Daniel Loriaux, Rupen Desai, Maragatha Kuchibhatla, Isaac O. Karikari, Carlos A. Bagley, Oren N. Gottfried


  • Risk Assessment and Characterization of 30-Day Perioperative Myocardial Infarction Following Spine Surgery

    by Timothy Y. Bs Wang, Joel R. Martin, Daniel B. Bs Loriaux, Rupen Bs Desai, Ronnie L. Bs Shammas, Owoicho Adogwa, Jessica Ms Moreno, Maragatha Kuchibhatla, Carlos A. Bagley, Isaac O. Karikari, et al.

    Study Design. A retrospective review. Objective. The aim of the study was to perform a risk assessment of 30-day perioperative myocardial infarction (MI) for spine surgery patients. Summary of Background Data. There is an increased emphasis to reduce complications and improve outcomes after spinal surgery. One of the more devastating perioperative complications of spinal surgery is MI. Methods. We evaluated all medical records of 1346 consecutive patients who underwent spinal surgery at a single institution from 2008 to 2010 for incidence of MI within 30 days of surgery and documented all demographic, preoperative, and operative variables. Associations between postoperative MI and individual risk factors were determined using logistic regression analysis. Patients were stratified into emergent and elective groups and a similar analysis was performed. Results. Overall, 22 patients (1.6%) had 30-day perioperative MI, 14 patients (1.2%) undergoing elective surgery, and 8 patients (4.2%) after emergent surgery (P = 0.047). Three (13.6%) patients experienced 30-day mortality and an additional 3 (13.6%) patients experienced mortality within 1 year. Multivariate logistic regression determined that age more than 65 years, atrial fibrillation, hypertension, prior MI, anticoagulant use, low albumin, length of stay more than 7 days, intraoperative transfusion, trauma etiology, baseline creatinine more than 1 mg/dL, and at least 2 levels of spinal fusion were predictive of postoperative MI. For patients undergoing emergent surgery, age more than 65 years was associated with an increased risk of postoperative MI. When stratified by elective surgery, we found that age more than 65, postoperative stay more than 7 days, intraoperative blood transfusion, baseline creatinine more than 1 mg/dL, and fusion of more than 1 level were associated with an increased risk of MI. Conclusion. The present study demonstrates a low incidence of MI after elective surgery with a higher incidence after emergent spine surgery and identifies patient factors predictive of postoperative MI. Level of Evidence: 3


  • Independent Predictors of 30-Day Perioperative Deep Vein Thrombosis in 1346 Consecutive Patients After Spine Surgery

    by Timothy Y. Wang, Jeffrey T. Sakamoto, Gautam Nayar, Visakha Suresh, Daniel B. Loriaux, Rupen Desai, Joel R. Martin, Owoicho Adogwa, Jessica Moreno, Carlos A. Bagley, et al.


  • Experience With Intrawound Vancomycin Powder for Spinal Deformity Surgery

    by Joel R. Martin, Owoicho Adogwa, Christopher R. Brown, Carlos A. Bagley, William J. Richardson, Shivanand P. Lad, Maragatha Kuchibhatla, Oren N. Gottfried

    Study Design. Retrospective cohort study. Objective. To evaluate the ability of local vancomycin powder to prevent deep wound infection after thoracolumbar and lumbar spinal fusion for open deformity cases. Summary of Background Data. Recent studies report that local delivery of vancomycin powder is associated with a decrease in spinal surgical site infection (SSI). This study compares deformity fusion cases before and after the routine application of spinal vancomycin powder. Methods. Posterior spinal deformity surgical procedures by a single institution were reviewed from January 2011 to April 2013. Routine application of vancomycin powder started in April 2012. Inclusion criteria included adult patients who underwent posterior fusion for deformity pathologies, including spondylolisthesis, kyphosis, sagittal imbalance, and scoliosis. Each cohort's baseline characteristics including infection risk factors, operative data, and rates of wound infection were compared. Associations between infection and vancomycin powder, with and without propensity score adjustment for risk factors were determined using logistic regression. Results. A total of 306 patients were included in the study. All measured baseline and operative variables were statistically similar between untreated (n = 150) and those who received vancomycin powder (n = 156). No significant change in deep wound infection rate was seen between the control (5.3%) and intervention group (5.1%, P = 0.936). Logistic regression with and without propensity score adjusted for risk factors demonstrated that the use of vancomycin powder did not impact the development of SSI (odds ratio [95% confidence interval]: 1.01 [0.36–2.79], P = 0.9910) and (odds ratio [95% confidence interval]: 0.87 [0.31–2.42], P = 0.7876), respectively. Conclusion. The local application of powdered vancomycin was not associated with a significant difference in the rate of deep SSI after spinal deformity surgery, and other treatment modalities are necessary to limit infection for this high-risk group. This study is in contrary to prior studies, which have reported a decrease in SSI with vancomycin powder. Level of Evidence: 2


    • 1 September 2013
      • Vol. 23, 283-90

    Outcomes and complications following spinous process fixation: a single-center analysis of 192 cases.

    by Ranjith Babu, Oren N Gottfried, John C Stevenson

    Spinous process fixation (SPF) is presented as less invasive than pedicle screws. There has been little quantitative data to support this assertion, and "minimally invasive" has not been well defined in spine surgery. Length of stay (LOS) and blood loss (BL) were chosen as surrogate measures of "minimally invasive." A chart review was conducted on 192 lumbar fusion patients (374 levels). A backward-selection multiple-linear-regression was performed to determine what variables contribute to LOS and estimated blood loss (EBL). A logistic regression controlling for age and number of levels on complication rates was also performed. Number of levels with supplementary screw fixation (SSF) was significantly associated with LOS (p = 0.003). Controlling for number of surgical levels, LOS increased by 0.30 days (95% CI: 0.02-0.58) for each level with SSF. For each additional level including SSF, BL increases by 25.31 cc (95% CI: 3.50-47.12, p = 0.023). Interbody fusion increases blood loss by 68.16 cc (95% CI: 17.18-119.13, p = .009). For each additional level with SSF, odds of perioperative complications increase by OR = 2.34 (95% CI: 1.35-4.05). Long-term complications were not affected by instrumentation. LOS and BL are increased in patients with SSF vs. SPF only. Odds of perioperative complications are increased in patients with SSF relative to those treated with SPF alone.